WMIF MAIN SITE
2026 Event SiteThe 2019 World Medical Innovation Forum will focus on Artificial Intelligence (AI) and its growing impact on clinical care.
This meeting brought together global leaders in the emerging discipline of artificial intelligence and machine learning for in-depth conversations on the fast-developing novel technologies that characterize the early era of adoption. Impact on patients, clinicians and systems were examined in depth. The Forum panels, consisting of industry and investment executives, teamed with Harvard clinical and research leaders, focused on patient interactions across care settings, and the role technology and data can play in advancing knowledge discovery and care delivery.
Deputy Commissioner, FDA
Secretary of Health and Human Services
President and Co-Founder, LunaDNA
CEO, Nuance Communications
CEO, Amgen
CEO, American Heart Association
U.S. Secretary of Defense, 2015–2017
Partner, Atlas Venture
CEO, NVIDIA
President, Health Platforms, Verily Life Sciences
Managing Partner, Qiming Venture Partners
CEO, Siemens Healthineers
CEO, GE Healthcare
CEO, Wolters Kluwer Health
Member of the Board of Management, Bayer AG; – President, Pharmaceutical, Bayer AG
Vice Chairman, Corporate and Investment Banking, Citigroup
CEO, NHS England
CEO, Philips
Administrator, Centers for Medicare and Medicaid Services
SVP, Head of Innovation and Health Equity, Microsoft Healthcare
Early career Harvard Medical School investigators kicked-off the World Medical Innovation Forum with rapid fire presentations of their high potential new technologies. Eighteen rising stars from Brigham Health and Massachusetts General Hospital highlighted the potential of their research in artificial intelligence, cognitive computation, machine learning, and big data in ten minute presentations. This session was designed for investors, entrepreneurs, investigators, donors and others who share a passion for accelerating the application of high impact technologies to the benefit of patients.
Watch Panel HereThe Innovation Discovery Grants (IDG) program aims to enhance the commercial outcomes of the Partners HealthCare community and increase its innovative potential. It is designed to stimulate new inventive concepts, identify areas of commercially significant scientific strength and accelerate commercialization of PHS intellectual assets. In 2018, the IDG program funded projects that focused on the advancement of opportunities where artificial intelligence can be used to improve clinical care.
Watch Panel Here
We use cookies to improve your browsing experience, analyze website traffic, and personalize content. By clicking “Accept All” you consent to our use of cookies. You can manage your preferences at any time. See our Privacy Policy.
We use cookies to run this site and, with your permission, to analyze traffic and personalize content. Choose which cookies to allow. See our Privacy Policy.
Required for the website to work. Always active.
Lets us measure website traffic and personalize content through Google Analytics. Nothing loads until you allow it.